Valomaciclovir stearate

DB15651InvestigationalSmall molecule

Valomaciclovir stearate is under investigation in clinical trial NCT00831103 (A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster).

Chemical structure of Valomaciclovir stearate
Formula / weight
C33H58N6O5 · 618.864 g/mol (avg)
Code names
A-174606.0 · ABT-606 · EPB 348 · MIV-606

Resolves to

Compound
UNII506LI1B3A3CAS195156-77-5ChEMBLCHEMBL2105845
Structure
InChIKeyACBSZTQIFTYFGH-IAPPQJPRSA-NSMILESCCCCCCCCCCCCCCCCCC(=O)OC[C@H](CCOC(=O)[C@@H](N)C(C)C)CN1C=NC2=C1N=C(N)NC2=O
Targets
P04293DNA polymerase catalytic subunit

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Valomaciclovir stearate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In